Delhi Man Takes HIV Preventive Drugs on AI advice, Condition Critical Anshika Mishra2 Feb 2026 5:47 PM ISTA Delhi-based man is reportedly in a critical condition after consuming HIV preventive medication based on guidance received from an artificial...
Health Bulletin 02/February/2026 Anshika Mishra2 Feb 2026 5:42 PM ISTHere are the top health stories for the day:65 Medical Colleges Yet to Submit MBBS Intern Stipend Details to NMC: RTIAround 65 medical colleges across...
Delhi Man Takes HIV Prevention Drugs on AI Advice, Lands in ICU Parthika Patel31 Jan 2026 6:04 PM ISTNew Delhi: A Delhi-based man is reportedly in a critical condition after consuming HIV preventive medication based on guidance received from an...
Drug Safety Alert: IPC Links Erythromycin Use to Fixed Drug Eruption Susmita Roy26 Jan 2026 3:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), in its latest Drug Safety Alert for September 2025, has reported a safety signal indicating that...
Scan to Report: Tamil Nadu Mandates QR Codes in Pharmacies for ADR Reporting Parthika Patel2 Jan 2026 5:32 PM ISTChennai: In a major step to bolster drug safety monitoring across the state, authorities in Tamil Nadu have mandated that all pharmacies must...
Attention Chemists: All Pharmacies to Mandatorily Display PvPI QR Code, ADR Toll-Free Number Susmita Roy22 Nov 2025 3:22 PM ISTNew Delhi: Every chemist and pharmacist in the country will now be required to mandatorily display the Pharmacovigilance Programme of India (PvPI) QR...
8 Drug Batches from 3 Pharma Firms Banned in Punjab After ADR Reports Susmita Roy14 Oct 2025 5:59 PM ISTAmritsar: Following multiple reports of suspected Adverse Drug Reactions (ADRs) from district hospitals and other public health institutions, the...
Drug Safety Alert: IPC Flags Adverse Reactions linked to Tranexamic acid and Metoclopramide Susmita Roy7 Sept 2025 1:30 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), in its latest drug safety alert for August, has reported safety signals indicating that the...
MSN Labs Gets CDSCO Panel Nod to Begin Phase III Trial of Cenobamate Tablets, With Safety Caveat Dr. Divya Colin5 Aug 2025 4:15 PM ISTNew Delhi: Considering the bioequivalence study results of the MSN Labs Cenobamate Tablets 12.5 mg, 25 mg, 50mg, 100 mg, 150 mg & 200 mg, the...
Rare Case Links Apixaban to Severe Periorbital Dermatitis: Highlights Need for Vigilance in Dermatological Reactions Medha Baranwal15 May 2025 9:15 PM ISTUSA: In a rare clinical presentation, researchers have documented a case of periorbital dermatitis linked to the use of apixaban, a commonly...
Drug Safety Alert: IPC Flags Adverse Reactions to Metronidazole, Luliconazole, Dalteparin, Gliclazide, and Tramadol Susmita Roy28 March 2025 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of March, has revealed adverse drug...
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Beta blockers Susmita Roy5 Jan 2025 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of December, has revealed that...
